These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 25430625

  • 1. Managing children with chronic myeloid leukaemia.
    Baccarani M.
    Br J Haematol; 2015 Jun; 169(5):759-60. PubMed ID: 25430625
    [No Abstract] [Full Text] [Related]

  • 2. Managing children with chronic myeloid leukaemia--response to Baccarani.
    Millot F, Suttorp M.
    Br J Haematol; 2015 Jun; 169(5):760-1. PubMed ID: 25573033
    [No Abstract] [Full Text] [Related]

  • 3. Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.
    de la Fuente J, Baruchel A, Biondi A, de Bont E, Dresse MF, Suttorp M, Millot F, International BFM Group (iBFM) Study Group Chronic Myeloid Leukaemia Committee.
    Br J Haematol; 2014 Oct; 167(1):33-47. PubMed ID: 24976289
    [Abstract] [Full Text] [Related]

  • 4. Another set of guidelines for chronic myeloid leukaemia.
    Clark RE.
    Br J Haematol; 2020 Oct; 191(2):147-149. PubMed ID: 32712951
    [No Abstract] [Full Text] [Related]

  • 5. [Early monitoring of BCR-ABL transcript levels and cytogenetic in assessing the prognosis of chronic myeloid leukemia].
    Huang Q, Zhang XY, Li Y, Wang XM.
    Zhonghua Yi Xue Za Zhi; 2013 Oct 15; 93(38):3049-53. PubMed ID: 24417926
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
    Hughes T, Branford S.
    Blood Rev; 2006 Jan 15; 20(1):29-41. PubMed ID: 16426942
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Standardisation of molecular monitoring for chronic myeloid leukaemia.
    Cross NC.
    Best Pract Res Clin Haematol; 2009 Sep 15; 22(3):355-65. PubMed ID: 19959086
    [Abstract] [Full Text] [Related]

  • 10. Long-lasting haematological remission despite persistence of the Philadelphia-positive clone in an untreated chronic myeloid leukaemia patient.
    Hilbe W, Sill H, Eisterer W, Lin F, Bechter O, Grünewald K, Thaler J.
    Acta Haematol; 1998 Sep 15; 100(2):101-3. PubMed ID: 9792944
    [No Abstract] [Full Text] [Related]

  • 11. BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
    Maël H, Audrey B, Evelyne CB, Pierre-Yves D, Kaddour C, Gilles S, Arnaud P.
    Ann Hematol; 2017 Feb 15; 96(2):335-336. PubMed ID: 27761606
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
    Tanzer J.
    Rev Prat; 1988 Jun 16; 38(18):1210-6. PubMed ID: 3175491
    [No Abstract] [Full Text] [Related]

  • 13. Chronic myeloid leukaemia presenting with bilateral papilloedema.
    Keh YS, Mathur S, Naqvi S, Shaunak S.
    Br J Hosp Med (Lond); 2021 Jan 02; 82(1):1. PubMed ID: 33512295
    [No Abstract] [Full Text] [Related]

  • 14. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.
    De Matteis G, Veneri D, Aprili F, Benati M, Paviati E, Guidi GC, Pizzolo G, Tecchio C.
    Ann Hematol; 2013 Mar 02; 92(3):413-5. PubMed ID: 23053185
    [No Abstract] [Full Text] [Related]

  • 15. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
    Müller MC, Gattermann N, Lahaye T, Deininger MW, Berndt A, Fruehauf S, Neubauer A, Fischer T, Hossfeld DK, Schneller F, Krause SW, Nerl C, Sayer HG, Ottmann OG, Waller C, Aulitzky W, le Coutre P, Freund M, Merx K, Paschka P, König H, Kreil S, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Dec 02; 17(12):2392-400. PubMed ID: 14523462
    [Abstract] [Full Text] [Related]

  • 16. [Actual aspects of chronic myeloid leukemia].
    Aguayo-González A, Tuna-Aguilar EJ.
    Rev Invest Clin; 2012 Dec 02; 64(2):192-8. PubMed ID: 22991781
    [No Abstract] [Full Text] [Related]

  • 17. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
    Bartley PA, Ross DM, Latham S, Martin-Harris MH, Budgen B, Wilczek V, Branford S, Hughes TP, Morley AA.
    Int J Lab Hematol; 2010 Dec 02; 32(6 Pt 1):e222-8. PubMed ID: 20491997
    [Abstract] [Full Text] [Related]

  • 18. Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology.
    van Kooten Niekerk PB, Roug AS, Petersen CC, Ommen HB, Kjeldsen E, Bendix K, Nyvold CG, Nederby L, Hokland P.
    Br J Haematol; 2013 Jul 02; 162(1):141-4. PubMed ID: 23593974
    [No Abstract] [Full Text] [Related]

  • 19. Acute abdomen in a patient with chronic myeloid leukaemia.
    Voppuru SR, Patkar S.
    Indian J Med Res; 2020 Nov 02; 152(Suppl 1):S134-S135. PubMed ID: 35345168
    [No Abstract] [Full Text] [Related]

  • 20. Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon.
    Ellis M, Mills AK.
    Intern Med J; 2015 Mar 02; 45(3):358-9. PubMed ID: 25735582
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.